Golrang Pharmaceutical Investment(GPI) Human Capital Report

  • About Us
    • Golrang Pharmaceutical Investment
    • Golrang Industrial Group
  • Subsidiary Companies
    • Faran Shimi
    • Varian Pharmed
    • Arian Salamat Sina
    • Hita pharma
    • Abian Darou
    • Salamat Pakhsh Hasti
    • Azar Zist Darou
    • Abian Pharmed
    • Pazhouhesh Gostaran Taghzieh Asan
    • Soroush Mana Pharmed
    • Vanda Pharmed
    • Pharmed Salamat Sina
    • Aban Darman Behbood
    • Tivan Tamin Pars
  • News & Media
  • Career Opportunities
  • Contact Us
  • About Us
    • Golrang Pharmaceutical Investment
    • Golrang Industrial Group
  • Subsidiary Companies
    • Faran Shimi
    • Varian Pharmed
    • Arian Salamat Sina
    • Hita pharma
    • Abian Darou
    • Salamat Pakhsh Hasti
    • Azar Zist Darou
    • Abian Pharmed
    • Pazhouhesh Gostaran Taghzieh Asan
    • Soroush Mana Pharmed
    • Vanda Pharmed
    • Pharmed Salamat Sina
    • Aban Darman Behbood
    • Tivan Tamin Pars
  • News & Media
  • Career Opportunities
  • Contact Us
Instagram Telegram Linkedin Globe-africa
حضور گروه سرمایه گذاری دارویی گلرنگ در پنجمین نمایشگاه کار ایران

The Participation of Golrang Pharmaceutical Investment Co. In The 5th Iran Job Fair

Varian Pharmed Introduce Its New Product, Three-Month Slow-Release Triptorelin, to Iran’s Pharmaceutical Market

A Training Course on Volunteer Firefighting and Special Situation Response

Golrang Pharmaceutical Holding Unveil 9 new products at the 7th International Exhibition on Pharmaceuticals and Related Industries IRANPHARMA EXPO 2022

Abyan Daru Co. Among Top 5 Producers of Pharmaceutical Supplements in Iran

Faranpharmed Introduce Three New Natural Products to Iran’s Pharmaceutical Market

Distributing Pharmaceutical in Iran Goes Intelligent

Abyan Pharmed’s Experts Manufacture Neurological Products, Cutting Down International Currency Needed to Import Medications

Developing Necessary Technical Knowledge to Manufacture APIs Needed by the Iranian Pharmaceutical Industry

Commissioning Hazardous Medications Production Line by the end of March 2023

Previous 1 … 4 5 6 7 8 Next

Latest

  • Establishment of the Pharmaceutical Commission of the Iran–India Joint Chamber of Commerce at the Proposal of GPI co.
  • Participation of Golrang Drug and Health Innovation Center in Tehran University of Medical Sciences Research and Technology Ecosystem Program
  • Launch of “OctaHeal Alpha‑Lipoic Acid” Supplement for Diabetic Patients by Faran Shimi
  • Participation of Golrang Pharmaceutical Group in the Afghan Health Exhibition in Kabul
  • Evaluation of 9 Innovative Projects in the Pharmaceutical and Health Sector at Golrang Pharmaceutical Investment Group Innovation Center for Investment and Partnership
  • No 63, After Kordestan bridge,
    Mollasadra St, Vanak Sq, Tehran, IRI.
  • 1991614851
  • +982124852000
  • +982124852150
  • info@golrangpi.com
Instagram Telegram Linkedin Globe
  • Golrang Industrial Group
  • Food and Drug Administration of The Iran

All rights reserved for Golrang Pharmaceutical Investment Company.